148 related articles for article (PubMed ID: 37920134)
1. Impact assessment of metabolite instability in the development and validation of LC-MS/MS bioanalytical assays for measurement of rosuvastatin in human plasma and urine samples.
Cui Y; Kowalski K; Van Parys M; Miller D; Hansen P; Liang X; Dean B; Chen L
Biomed Chromatogr; 2024 Jan; 38(1):e5766. PubMed ID: 37920134
[TBL] [Abstract][Full Text] [Related]
2. Quantitation of parent drug and its unstable metabolites by in situ coulometric oxidation and liquid chromatography-tandem mass spectrometry.
Tong W; Chowdhury SK; Su AD; Alton KB
Anal Chem; 2010 Dec; 82(24):10251-7. PubMed ID: 21105697
[TBL] [Abstract][Full Text] [Related]
3. A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Macwan JS; Ionita IA; Akhlaghi F
Anal Bioanal Chem; 2012 Jan; 402(3):1217-27. PubMed ID: 22108655
[TBL] [Abstract][Full Text] [Related]
4. UHPLC-MS/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV.
Courlet P; Spaggiari D; Desfontaine V; Cavassini M; Alves Saldanha S; Buclin T; Marzolini C; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1125():121733. PubMed ID: 31374423
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous LC-MS/MS analysis of simvastatin, atorvastatin, rosuvastatin and their active metabolites for plasma samples of obese patients underwent gastric bypass surgery.
El-Zailik A; Cheung LK; Wang Y; Sherman V; Chow DS
J Pharm Biomed Anal; 2019 Feb; 164():258-267. PubMed ID: 30396053
[TBL] [Abstract][Full Text] [Related]
6. Challenges and recommendations in developing LC-MS/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites.
Yuan L; Sophia Xu X; Ji QC
Bioanalysis; 2020 May; 12(9):615-624. PubMed ID: 32441529
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous quantitation of rosuvastatin and ezetimibe in human plasma by LC-MS/MS: Pharmacokinetic study of fixed-dose formulation and separate tablets.
Bhadoriya A; Sanyal M; Shah PA; Shrivastav PS
Biomed Chromatogr; 2018 Oct; 32(10):e4291. PubMed ID: 29782035
[TBL] [Abstract][Full Text] [Related]
8. A strategy for a post-method-validation use of incurred biological samples for establishing the acceptability of a liquid chromatography/tandem mass-spectrometric method for quantitation of drugs in biological samples.
Jemal M; Ouyang Z; Powell ML
Rapid Commun Mass Spectrom; 2002; 16(16):1538-47. PubMed ID: 12203245
[TBL] [Abstract][Full Text] [Related]
9. Challenges and solutions in the bioanalysis of BMS-986094 and its metabolites including a highly polar, active nucleoside triphosphate in plasma and tissues using LC-MS/MS.
Liu A; Lute J; Gu H; Wang B; Trouba KJ; Arnold ME; Aubry AF; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():29-40. PubMed ID: 26209768
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.
Abdel-Megied AM; Eldehna WM; Abdelrahman MA; Elbarbry FA
Molecules; 2020 Dec; 25(23):. PubMed ID: 33291270
[TBL] [Abstract][Full Text] [Related]
11. An LC-MS/MS spectrometry method for the simultaneous determination of Rosuvastatin and Irbesartan in rat plasma: Insight into pharmacokinetic and drug-drug interaction studies.
Elgawish MS; Soltan MK; Sebaiy MM
J Pharm Biomed Anal; 2019 Sep; 174():226-234. PubMed ID: 31181484
[TBL] [Abstract][Full Text] [Related]
12. Simple LC-MS/MS methods for simultaneous determination of pitavastatin and its lactone metabolite in human plasma and urine involving a procedure for inhibiting the conversion of pitavastatin lactone to pitavastatin in plasma and its application to a pharmacokinetic study.
Qi X; Ding L; Wen A; Zhou N; Du X; Shakya S
J Pharm Biomed Anal; 2013 Jan; 72():8-15. PubMed ID: 23146221
[TBL] [Abstract][Full Text] [Related]
13. Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
Hendrikx JJ; Dubbelman AC; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1925-34. PubMed ID: 23939959
[TBL] [Abstract][Full Text] [Related]
14. Optimized LC-MS/MS quantification of tuberculosis drug candidate macozinone (PBTZ169), its dearomatized Meisenheimer Complex and other metabolites, in human plasma and urine.
Desfontaine V; Guinchard S; Marques S; Vocat A; Moulfi F; Versace F; Huser-Pitteloud J; Ivanyuk A; Bardinet C; Makarov V; Ryabova O; André P; Prod'Hom S; Chtioui H; Buclin T; Cole ST; Decosterd L
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1215():123555. PubMed ID: 36563654
[TBL] [Abstract][Full Text] [Related]
15. Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry.
Xu DH; Ruan ZR; Zhou Q; Yuan H; Jiang B
Rapid Commun Mass Spectrom; 2006; 20(16):2369-75. PubMed ID: 16841359
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of LC-MS/MS methods for the quantification of the novel anticancer agent guadecitabine and its active metabolite β‑decitabine in human plasma, whole blood and urine.
Roosendaal J; Wang K; Rosing H; Lucas L; Gebretensae A; Oganesian A; Schellens JHM; Beijnen JH; Lin ZJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Mar; 1109():132-141. PubMed ID: 30754019
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of LC-MS/MS methods for the quantification of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, and its main metabolite M6 in human plasma, urine and feces: Application to a clinical study in healthy Chinese subjects.
Gao H; Cheng M; Liu H; Ding L
J Pharm Biomed Anal; 2023 Sep; 233():115498. PubMed ID: 37285657
[TBL] [Abstract][Full Text] [Related]
18. Importance of measuring pharmacologically active metabolites of edoxaban: development and validation of an ultra-high-performance liquid chromatography coupled with a tandem mass spectrometry method.
Siriez R; Alpan L; Elasaad K; Devel P; Laloy J; Dogné JM; Douxfils J
J Thromb Thrombolysis; 2020 Apr; 49(3):395-403. PubMed ID: 31925664
[TBL] [Abstract][Full Text] [Related]
19. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous Determination of Rosuvastatin, Rosuvastatin-5 S-lactone, and N-desmethyl Rosuvastatin in Human Plasma by UPLC-MS/MS and Its Application to Clinical Study.
Bai X; Wang XP; He GD; Zhang B; Huang M; Li JL; Zhong SL
Drug Res (Stuttg); 2018 Jun; 68(6):328-334. PubMed ID: 29232752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
